Skip to main content

Advertisement

SpringerLink
Log in

Adalimumab for the treatment of refractory noninfectious paediatric uveitis

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To report the experience of our center with the use of adalimumab (ADA) for the treatment of severe refractory noninfectious paediatric uveitis. The study is a retrospective case series of all paediatric patients with refractory uveitis who were treated with ADA at the Paediatric Uveitis Unit of our center from 2008 to 2015. We present 12 patients (6 Juvenile idiopathic arthritis-associated uveitis, 4 idiopathic panuveitis, 1 early-onset sarcoidosis-associated panuveitis, and 1 intermediate uveitis), with uveitis in 19/24 eyes. Once ADA therapy was started, all the patients presented improved activity according to Standardization of Uveitis Nomenclature (SUN) criteria. Nine out of the 12 patients had structural damage before ADA could be started: cataract (n = 4), glaucoma (n = 2), cystic macular edema (n = 1), exudative retinal detachment (n = 1), and optic disk edema (n = 5). Visual acuity improved or maintained stable in 17/19 affected eyes, and only 2 eyes decreased its visual acuity because of structural damage, which was already present before ADA therapy. In our experience, ADA presents a good safety profile and is efficacious in the treatment of paediatric patients with different forms of refractory noninfectious uveitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Simonini G, Taddio A, Cattalini M, Caputo R, de Libero C, Parentin F, Pagnini I, Lepore L, Cimaz R (2013) Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. Pediatr Rheumatol Online J 11:16. doi:10.1186/1546-0096-11-16

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nagpal A, Leigh JF, Acharya NR (2008) Epidemiology of uveitis in children. Int Ophthalmol Clin 48(3):1–7. doi:10.1097/IIO.0b013e31817d740e

    Article  PubMed  Google Scholar 

  3. Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V (2012) Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken) 64(9):1365–1372. doi:10.1002/acr.21674

    Article  Google Scholar 

  4. Cordero-Coma M, Sobrin L (2015) Anti-tumor necrosis factor-α therapy in uveitis. Surv Ophthalmol 60(6):575–589. doi:10.1016/j.survophthal.2015.06.004

    Article  PubMed  Google Scholar 

  5. Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kacmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH (2013) Response of pediatric uveitis to tumor necrosis factor-alpha inhibitors. J Rheumatol 40(8):1394–1403. doi:10.3899/jrheum.121180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Januschowski K, Voykov B, Deuter C (2014) Immunomodulatory therapy with tumour necrosis factor alpha inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol 98(4):523–528. doi:10.1136/bjophthalmol-2013-303935

    Article  PubMed  Google Scholar 

  7. Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F (2013) Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol 40(1):74–79. doi:10.3899/jrheum.120583

    Article  CAS  PubMed  Google Scholar 

  8. Simonini G, Taddio A, Cattalini M, Caputo R, De Libero C, Naviglio S, Bresci C, Lorusso M, Lepore L, Cimaz R (2011) Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res (Hoboken) 63(4):612–618. doi:10.1002/acr.20404

    Article  CAS  Google Scholar 

  9. Bou R, Adan A, Borras F, Bravo B, Calvo I, De Inocencio J, Diaz J, Escudero J, Fonollosa A, de Vicuna CG, Hernandez V, Merino R, Peralta J, Rua MJ, Tejada P, Anton J (2015) Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int 35(5):777–785. doi:10.1007/s00296-015-3231-3

    Article  PubMed  Google Scholar 

  10. Reiff A, Kadayifcilar S, Ozen S (2013) Rheumatic inflammatory eye diseases of childhood. Rheum Dis Clin North Am 39(4):801–832. doi:10.1016/j.rdc.2013.05.005

    Article  PubMed  Google Scholar 

  11. Marino A, Pagnini I, Giani T, Caputo R, Arapi I, Neri P, Cimaz R, Simonini G (2016) Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis. Int Ophthalmol 36(1):129–135. doi:10.1007/s10792-015-0135-x

    Article  Google Scholar 

  12. Neri P, Eandi C, Arapi I, Posarelli C, Mariotti C, Giovannini A (2013) Long-term control of non-infectious paediatric panuveitis refractory to traditional immunesuppressive therapy, successfully treated with Adalimumab (HumiraTM). Clin Exp Rheumatol 31(3):458–462

    PubMed  Google Scholar 

  13. Imrie FR, Dick AD (2007) Biologics in the treatment of uveitis. Curr Opin Ophthalmol 18(6):481–486. doi:10.1097/ICU.0b013e3282f03d42

    Article  PubMed  Google Scholar 

  14. Schmeling H, Horneff G (2005) Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 44(8):1008–1011. doi:10.1093/rheumatology/keh658

    Article  CAS  Google Scholar 

  15. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516

    Article  PubMed  Google Scholar 

  16. Angeles-Han ST, Griffin KW, Lehman TJ, Rutledge JR, Lyman S, Nguyen JT, Harrison MJ (2010) The importance of visual function in the quality of life of children with uveitis. J AAPOS 14(2):163–168. doi:10.1016/j.jaapos.2009.12.160

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lam LA, Lowder CY, Baerveldt G, Smith SD, Traboulsi EI (2003) Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol 135(6):772–778

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Paediatric Ophthalmology, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain

    Alicia Muñoz-Gallego, Pilar Tejada & Ana Barceló

  2. Section of Paediatric Rheumatology, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain

    Estefanía Barral, Eugenia Enríquez & Jaime de Inocencio

Authors
  1. Alicia Muñoz-Gallego
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Estefanía Barral
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugenia Enríquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pilar Tejada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Barceló
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jaime de Inocencio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alicia Muñoz-Gallego.

Ethics declarations

Conflict of interest

The authors of this manuscript declare that they do not have any conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muñoz-Gallego, A., Barral, E., Enríquez, E. et al. Adalimumab for the treatment of refractory noninfectious paediatric uveitis. Int Ophthalmol 37, 719–725 (2017). https://doi.org/10.1007/s10792-016-0293-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0293-5

Keywords

Search

Navigation